Phase II trial of Immunotech's IPF-ITV-1 in patients with advanced HIV-AIDS
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2014
At a glance
- Drugs ITV 1 (Primary)
- Indications Acquired immunodeficiency syndrome; HIV infections
- Focus Therapeutic Use
- 28 Aug 2014 Status changed from planning to completed.
- 01 Mar 2013 Planned initiation date changed from 1 Mar 2013 to 1 May 2013, as reported in an Immunotech Laboratories media release.
- 01 Mar 2013 Planned End Date changed from 1 Aug 2013 to 1 Oct 2013, as reported in an Immunotech Laboratories media release.